Your browser doesn't support javascript.
loading
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesin.
Berndsen, Zachary T; Akhtar, Marjahan; Thapa, Mahima; Vickers, Tim; Schmitz, Aaron; Torres, Jonathan L; Baboo, Sabyasachi; Kumar, Pardeep; Khatoom, Nazia; Sheikh, Alaullah; Hamrick, Melissa; Diedrich, Jolene K; Martinez-Bartolome, Salvador; Garrett, Patrick T; Yates, John R; Turner, Jackson S; Laird, Renee M; Poly, Frédéric; Porter, Chad K; Copps, Jeffrey; Ellebedy, Ali H; Ward, Andrew B; Fleckenstein, James M.
Afiliación
  • Berndsen ZT; Department of Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA.
  • Akhtar M; Department of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, USA.
  • Thapa M; Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, USA. Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St Louis, MO, USA and The Andrew M. and Jane M. Bursky Center for Human Imm
  • Vickers T; Department of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, USA.
  • Schmitz A; Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, USA. Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St Louis, MO, USA and The Andrew M. and Jane M. Bursky Center for Human Imm
  • Torres JL; Department of Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA.
  • Baboo S; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
  • Kumar P; Department of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, USA.
  • Khatoom N; Department of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, USA.
  • Sheikh A; Department of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, USA.
  • Hamrick M; Department of Medicine, Division of Infectious Diseases, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, USA.
  • Diedrich JK; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
  • Martinez-Bartolome S; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
  • Garrett PT; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
  • Yates JR; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
  • Turner JS; Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, USA. Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St Louis, MO, USA and The Andrew M. and Jane M. Bursky Center for Human Imm
  • Laird RM; Operationally Relevant Infections Department, Naval Medical Research Command (NMRC), Silver Spring, Maryland, USA.
  • Poly F; Operationally Relevant Infections Department, Naval Medical Research Command (NMRC), Silver Spring, Maryland, USA.
  • Porter CK; Naval Medical Research Command (NMRC), Silver Spring, Maryland, USA.
  • Copps J; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Ellebedy AH; Department of Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA.
  • Ward AB; Department of Pathology and Immunology, Washington University in Saint Louis, School of Medicine. Saint Louis, Missouri, USA. Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St Louis, MO, USA and The Andrew M. and Jane M. Bursky Center for Human Imm
  • Fleckenstein JM; Department of Integrative Structural and Computational Biology, Scripps Research, La Jolla, CA, USA.
bioRxiv ; 2024 May 08.
Article en En | MEDLINE | ID: mdl-38766097
ABSTRACT
Enterotoxigenic Escherichia coli (ETEC) cause hundreds of millions of cases of infectious diarrhea annually, predominantly in children from low-middle income regions. Notably, in children, as well as human volunteers challenged with ETEC, diarrheal severity is significantly increased severity in blood group A (bgA) individuals. EtpA, is a secreted glycoprotein adhesin that functions as a blood group A lectin to promote critical interactions between ETEC and blood group A glycans on intestinal epithelia for effective bacterial adhesion and toxin delivery. EtpA is highly immunogenic resulting in robust antibody responses following natural infection and experimental challenge of human volunteers with ETEC. To understand how EtpA directs ETEC-blood group A interactions and stimulates adaptive immunity, we mutated EtpA, mapped its glycosylation by mass-spectrometry (MS), isolated polyclonal (pAbs) and monoclonal antibodies (mAbs) from vaccinated mice and ETEC-infected human volunteers, and determined structures of antibody-EtpA complexes by cryo-electron microscopy. Both bgA and mAbs that inhibited EtpA-bgA interactions and ETEC adhesion, bound to the C-terminal repeat domain highlighting this region as crucial for ETEC pathogen-host interaction. MS analysis uncovered extensive and heterogeneous N-linked glycosylation of EtpA and cryo-EM structures revealed that mAbs directly engage these unique glycan containing epitopes. Finally, electron microscopy-based polyclonal epitope mapping revealed antibodies targeting numerous distinct epitopes on N and C-terminal domains, suggesting that EtpA vaccination generates responses against neutralizing and decoy regions of the molecule. Collectively, we anticipate that these data will inform our general understanding of pathogen-host glycan interactions and adaptive immunity relevant to rational vaccine subunit design.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos